Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection

Clinical trial NCT02413593 · COMPLETED

Trial details

NCT number: NCT02413593
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C Virus Infection

Start date: 2015-04-01
Primary completion: 2015-12-01
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.